Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

✓ Peer-reviewed alzhub usefulness score 25 out of 100. Treatments

Topic: Amyloid, tau and blood-test diagnosis

Plain-language summary

Progressive neurodegenerative disorder i.e. Alzheimer’s disease (AD) is characterized by cognitive decline, oxidative stress, and cholinergic dysfunction, β-amyloid aggregation, tau hyperphosphorylation. Plant-derived neuroprotective agents have gained increasing scientific attention due to their multi-target mechanisms and favorable safety profiles. This review aims to highlight the Alzheimer’s-suppressing potential of four traditionally important medicinal plants: Convolvulus pluricaulis, Curcuma longa, Withania somnifera, and Bacopa monnieri. C. pluricaulis has been reported to exhibit nootropic and anxiolytic effects mainly via cholinesterase inhibition and antioxidant activity. C. longa (Curcumin) has strong anti-amyloid, anti-inflammatory, and metal-chelating properties, offering protection against plaque formation and neuronal toxicity. W. somnifera (Withanolide) promotes synaptic regeneration, decreases oxidative stress, and provides amyloid and tau pathology modulation. B. monnieri, rich in bacosides and flavonoids, enhances cognitive performance by reducing oxidative damage, improving cholinergic function, and inhibiting β-amyloid aggregation. Altogether, these botanicals act through complementary pathways, including antioxidant defense, anti-inflammatory modulation, neurotransmitter regulation, and prevention of amyloid/tau pathology, thereby making them promising candidates for the integrative management of AD. Further clinical validation is essential to determine standardized doses and the long-term efficacy of these extracts, as well as synergistic potential in combination therapies.

What this study adds

Evidence grade: Low

This review describes four medicinal plants whose compounds are reported to act through antioxidant, anti-inflammatory, cholinergic and anti-amyloid/tau mechanisms relevant to Alzheimer's disease. It is a summary of reported plant properties and does not provide clinical trial evidence that these plants treat, cure or prevent the disease in people.

Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

APA 7th

Pawar, V. G., Patel, A., & Sanap, A. R. (2026). Review on Alzheimer-Suppressing Potential of different Medicinal plant. Research Journal of Science and Technology. https://doi.org/10.52711/2349-2988.2026.00026

Vancouver

Pawar VG, Patel A, Sanap AR. Review on Alzheimer-Suppressing Potential of different Medicinal plant. Research Journal of Science and Technology. 2026. doi:10.52711/2349-2988.2026.00026.

BibTeX

@article{pawar2026-f8a6f497,
  author  = {Pawar, Vikas G. and Patel, Arshu and Sanap, Aarti R.},
  title   = {{Review on Alzheimer-Suppressing Potential of different Medicinal plant}},
  journal = {Research Journal of Science and Technology},
  year    = {2026},
  doi     = {10.52711/2349-2988.2026.00026},
  url     = {https://doi.org/10.52711/2349-2988.2026.00026}
}

Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.

Key findings

Why it matters

This review describes four medicinal plants whose compounds are reported to act through antioxidant, anti-inflammatory, cholinergic and anti-amyloid/tau mechanisms relevant to Alzheimer's disease. It is a summary of reported plant properties and does not provide clinical trial evidence that these plants treat, cure or prevent the disease in people.

Study details

How this study scored 25/100
How this study's score is builtJournal tier 7 of 10; Journal's citation record 0 of 4; Study design 0 of 12; Strength of evidence 1 of 5; Peer-review validation 10 of 10; How recent 5 of 5; Sample size 0 of 4; Effect reported 0 of 3; Studied in people 0 of 3; Randomized / blinded 0 of 2; Times cited 0 of 7; Citations per year 0 of 5; Impact for its field and year 0 of 6; Cited by studies here 0 of 6; Still being cited 0 of 4; Senior author's track record left out, no data; Institution's track record 0 of 3; Multicenter collaboration 0 of 3; Indexed in PubMed 1 of 2; Free to read 0 of 2. 24 of the 96 points it could be judged on, which is 25 of 100. Total 25 of 100.24 of the 96 points we could judge = 25 of 100

Published in a peer-reviewed journal. Scored zero for study design, sample size, effect reported, studied in people and randomized / blinded because the record does not state it. We have no data on senior author's track record, so that was left out: it earned 24 of the 96 points we could judge it on, which is 25 out of 100.

ComponentPointsWhy
Journal tier 7 / 10 Tier 3 — peer-reviewed journal (Research Journal of Science and Technology)
Journal's citation record 0 / 4 Research Journal of Science and Technology: journal h-index 15 (OpenAlex, 2026-10-29)
Study design 0 / 12 No study design recorded — scores zero, not guessed (not stated in the record — scored 0)
Strength of evidence 1 / 5 Rated “low” in our summary
Peer-review validation 10 / 10 Peer-reviewed. Published as an article in a named peer-reviewed journal.
How recent 5 / 5 2026 — within 1 year(s) of the newest study here
Sample size 0 / 4 Participant count not stated — scores zero (not stated in the record — scored 0)
Effect reported 0 / 3 No effect size reported — scores zero (not stated in the record — scored 0)
Studied in people 0 / 3 Not stated whether this was studied in people — scores zero (not stated in the record — scored 0)
Randomized / blinded 0 / 2 No randomization or blinding stated — scores zero (not stated in the record — scored 0)
Times cited 0 / 7 Cited 0 times (OpenAlex, 2026-10-10)
Citations per year 0 / 5 0.0 citations a year over 2 year(s) since 2026
Impact for its field and year 0 / 6 Cited 0.0× the average for papers of its field and year (OpenAlex FWCI)
Cited by studies here 0 / 6 No other study in this library cites it
Still being cited 0 / 4 Cited 0 times in 2024–2026 (2026 still in progress; OpenAlex)
Senior author's track record — / 4 OpenAlex's profile for last-listed author Aarti R. Sanap holds only 4 work(s), too few to judge a track record — left out of this score
Institution's track record 0 / 3 Pravara Rural College of Pharmacy Pravaranagar: institution h-index 31 (OpenAlex)
Multicenter collaboration 0 / 3 OpenAlex lists 1 institution(s) in 0 countries — scores zero (affiliation lists can be incomplete)
Indexed in PubMed 1 / 2 Not in PubMed, but has a DOI
Free to read 0 / 2 Behind a paywall — scores zero
Points 24 / 96 Scored on 19 of 20 parts. We have no data for the rest, so they are left out: 24 of the 96 points we could judge it on is 25 out of 100.
Total 25 / 100 —

What each of these 20 components measures, and what this score is not →

Read the original

May need a subscription OpenAlex found no free copy of the full text (checked 6 Feb 1020), so the publisher may charge for it.

Studies in the library that share something with this one. The line above each title says what.

Studies this one cites

Referenced by this study and also in the alzhub library, so you can read them here.

Related studies in Treatments from nearby years

Also in Treatments

203 studies in the library are filed under Treatments with no topic tag they share with another; these are this study's neighbours in a fixed tour of them. The Treatments hub.

Similar studies

More on Treatments

See all studies in Treatments →